US Stock MarketDetailed Quotes

RHHBY ROCHE HOLDING AG

Watchlist
  • 41.050
  • -0.240-0.58%
15min DelayClose Feb 14 16:00 ET
  • 41.050
  • 0.0000.00%
Post 16:01 ET
261.67BMarket Cap22.32P/E (TTM)

About ROCHE HOLDING AG Company

Roche Holding AG is a research healthcare company. It operates through the Roche Pharmaceuticals and Diagnostics segments. The Roche Pharmaceutical division comprises the business segments, such as Roche Pharmaceuticals and Chuga. The Diagnostic division consists of the following four business areas: centralized and point of care solutions, molecular diagnostics, tissue diagnostics, and diabetes care. The company was founded by Fritz Hoffmann-La Roche on October 1, 1896 and is headquartered in Basel, Switzerland.

Company Profile

SymbolRHHBY
Company NameROCHE HOLDING AG
Founded1896
CEODr. Severin Schwan
MarketPink Market
Employees103605
Fiscal Year Ends12-31
AddressGrenzacherstrasse 124
CityBasel
ProvinceBasel-Stadt (Basle Town)
CountrySwitzerland
Zip Code4058
Phone41-61-688-11-11

Company Executives

  • Name
  • Position
  • Salary
  • Andre S. Hoffmann
  • Vice Chairman of the Board
  • --
  • Dr. Severin Schwan
  • Chairman of the Board
  • --
  • Bernard J. Poussot
  • Independent Director
  • --
  • Professor Dr. Richard P. Lifton
  • Independent Director
  • --
  • Patrick Frost
  • Independent Director
  • --
  • Dr. Jorg Duschmale
  • Independent Director
  • --
  • Dr. Claudia Sussmuth Dyckerhoff
  • Independent Director
  • --
  • Professor Dr. Akiko Iwasaki
  • Independent Director
  • --
  • Dr. Mark Schneider
  • Independent Director
  • --
  • Dr. Jemilah Mahmood
  • Independent Director
  • --
  • Anita Hauser
  • Independent Director
  • --

Trending Stocks

Discussing
Trump 2.0 Era: How will global markets evolve?
🎙️Discussion: 1. How will tariff policies affect the movement of key assets such as U.S. stocks, gold, and Bitcoin? 2. Given this context, Show More
Reassessing Chinese Assets
Following the introduction of China's groundbreaking DeepSeek technology, Wall Street giants have revised their investment outlooks for the Chinese market.